Drug class in one race
HIF prolyl hydroxylase (HIF-PH1/2/3) drugs for Chronic Kidney Disease
8 tracked HIF prolyl hydroxylase (HIF-PH1/2/3) drugs in the Chronic Kidney Disease race. The class explanation lives on the HIF prolyl hydroxylase (HIF-PH1/2/3) page; the full indication pipeline across every mechanism is on the Chronic Kidney Disease page.
2 approved / phase 45 Phase 31 Phase 2
Head-to-head evidence: AND017 vs Daprodustat · AND017 vs Desidustat · AND017 vs Enarodustat · AND017 vs Molidustat · AND017 vs Roxadustat · AND017 vs SSS17